Market revenue in 2023 | USD 25.9 million |
Market revenue in 2030 | USD 32.4 million |
Growth rate | 3.3% (CAGR from 2023 to 2030) |
Largest segment | Infectious diseases |
Fastest growing segment | Oncology |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oncology, Prenatal Testing, Endocrinology, Other Applications, Hematology, Infectious Diseases |
Key market players worldwide | Roche, Abbott Laboratories, Qiagen NV, Bayer AG, Nova Biomedical, Danaher Corp, Nipro Corp, Bio-Rad Laboratories Inc, Agilent Technologies Inc, BioMerieux SA, OraSure Technologies Inc, Abaxis |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to point-of-care molecular diagnostics market will help companies and investors design strategic landscapes.
Infectious diseases was the largest segment with a revenue share of 93.44% in 2023. Horizon Databook has segmented the Argentina point-of-care molecular diagnostics market based on oncology, prenatal testing, endocrinology, other applications, hematology, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.
Argentina is witnessing rapid urbanization and an increasing trend toward unhealthy diet, lower physical activity, and a rise in alcohol consumption & smoking. This has led to an increase in the prevalence of chronic diseases in the country and is anticipated to drive the adoption of a broad range of POC products.
For instance, according to a report published by UNAIDS, in 2020, there were more than 140,000 adults and children living with HIV in the country. Moreover, about 5,600 new cases were detected in 2020, while over 1,400 people died due to the disease. Therefore, a high prevalence of HIV/AIDS is anticipated to fuel the demand for POC testing.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina point-of-care molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Argentina point-of-care molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account